New Medicare‑Approved Devices for Sleep Apnea in 2025
If you’ve been diagnosed with obstructive sleep apnea (OSA), you may qualify for more advanced treatments covered by Medicare in 2025. Beyond CPAP, the latest Medicare‑approved medical devices—including implants, oral appliances, and wearable monitors—offer hope, convenience, and even potential relief for those who can’t tolerate traditional therapy.
If you’ve been diagnosed with obstructive sleep apnea (OSA), you may qualify for more advanced treatments covered by Medicare in 2025. Beyond CPAP, the latest Medicare‑approved medical devices—including implants, oral appliances, and wearable monitors—offer hope, convenience, and even potential relief for those who can’t tolerate traditional therapy.
1. Expanded Medicare Coverage for OSA Devices
Medicare Part B now covers a broader range of sleep apnea treatments beyond standard CPAP and BiPAP devices. That includes FDA‑approved oral appliances, regenerative therapy implants, and hypoglossal nerve stimulation systems—provided they’re deemed medically necessary by your doctor and supplied by a Medicare‑participating provider
2. What’s Covered in 2025
CPAP and BiPAP rentals or purchases: Covered under Part B after a sleep study confirms your OSA, with typical coinsurance at 20% after deductible
Inspire hypoglossal nerve stimulation implant: A mask‑free, FDA‑approved treatment for moderate to severe OSA if CPAP isn’t tolerated. Medicare now covers the implant, surgery, and follow‑up care under eligible circumstances
Oral appliances (mandibular advancement splints): Custom dental devices that shift your jaw forward to ease airway obstruction—covered when CPAP is unsuitable or for mild to moderate OSA
3. Newly Approved Wearable Diagnostics
In early 2025, Medicare began approving certain wearable pulse‑oximeter rings for at-home, FDA‑cleared sleep apnea screening. These ring monitors connect to phone apps and can improve diagnostic access vs. one-night lab studies. While not a treatment per se, they streamline the route to device eligibility and full coverage.
4. Who Qualifies for Each Device
To qualify for coverage:
Your doctor must order a Medicare‑approved sleep study (in-lab Type I or home-based Type II–IV), and confirm OSA diagnosis
For CPAP: consistent use during a 12‑week trial is required before full coverage continues.
For Inspire implants: you must have moderate‑to‑severe OSA, failed CPAP or BiPAP, favorable anatomy, and BMI within Medicare guidelines
For oral appliances: CPAP intolerance or mild‑moderate OSA under physician recommendation
5. What You’ll Pay Out‑of‑Pocket
Medicare Part B coinsurance is typically 20% of the approved amount after meeting the annual deductible (about $257 in 2025).
If provider or device supplier is not Medicare‑participating, you may face higher costs—or none of the coverage. Always confirm provider eligibility before proceeding.
6. How to Begin Accessing New Treatments
Get a Medicare‑approved sleep study ordered by your physician.
Discuss whether you’re a candidate for Inspire implants or oral devices — especially if CPAP hasn’t worked.
Ask about wearable ring monitors for at-home assessments if you’ve delayed testing.
Choose Medicare‑participating suppliers and providers to ensure coverage applies.
Check your Medicare Advantage or Supplement plan for cost-sharing details; some plans offer additional benefits like free breathing compliance tools.
Medicare-Covered Sleep Apnea Services
CPAP Therapy (CPAP Machines & Accessories)
Medicare Part B covers a 12-week trial of CPAP therapy—including devices and accessories—if you’ve been diagnosed with obstructive sleep apnea. If the therapy is effective and documented by your doctor, Medicare may continue long-term coverage. After about 13 months of rentals, the CPAP machine becomes your property.
Sleep Studies (Diagnostic Testing)
Medicare also covers sleep tests needed to diagnose OSA. This includes Type I (lab-based) and home-based (Type II–IV) sleep studies when clinical signs or symptoms of sleep apnea are present.
Hypoglossal Nerve Stimulation (Inspire)
Medicare supports hypoglossal nerve stimulation (e.g., the Inspire implant) for certain patients with moderate to severe OSA—especially those who are CPAP-intolerant. Specific coverage criteria must be met, including medical necessity and clinical eligibility. Details are outlined in local Medicare documentation.
Medicare coverage of sleep apnea devices has expanded in 2025. From mask-free implants like Inspire to custom oral appliances and wearable diagnostics, there are now more pathways to safe, effective treatment—often with limited personal expense. Start with a sleep study, consult your provider, and explore which new Medicare‑covered device fits your needs.